Adage Capital Partners’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-159,266
| Closed | -$15.9K | – | 974 |
|
2024
Q4 | $15.9K | Hold |
159,266
| – | – | ﹤0.01% | 861 |
|
2024
Q3 | $11.3K | Sell |
159,266
-2,059
| -1% | -$146 | ﹤0.01% | 844 |
|
2024
Q2 | $14K | Sell |
161,325
-20,475
| -11% | -$1.78K | ﹤0.01% | 839 |
|
2024
Q1 | $29.1K | Hold |
181,800
| – | – | ﹤0.01% | 848 |
|
2023
Q4 | $14.7K | Sell |
181,800
-100
| -0.1% | -$8 | ﹤0.01% | 829 |
|
2023
Q3 | $71.8K | Hold |
181,900
| – | – | ﹤0.01% | 817 |
|
2023
Q2 | $36.4K | Hold |
181,900
| – | – | ﹤0.01% | 837 |
|
2023
Q1 | $25.5K | Hold |
181,900
| – | – | ﹤0.01% | 899 |
|
2022
Q4 | $15.4K | Hold |
181,900
| – | – | ﹤0.01% | 945 |
|
2022
Q3 | $27K | Hold |
181,900
| – | – | ﹤0.01% | 1007 |
|
2022
Q2 | $47K | Hold |
181,900
| – | – | ﹤0.01% | 1040 |
|
2022
Q1 | $110K | Hold |
181,900
| – | – | ﹤0.01% | 1049 |
|
2021
Q4 | $209K | Hold |
181,900
| – | – | ﹤0.01% | 985 |
|
2021
Q3 | $211K | Buy |
+181,900
| New | +$211K | ﹤0.01% | 982 |
|